We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$254M
AUM Growth
+$22.2M
Cap. Flow
+$5.01M
Cap. Flow %
1.97%
Top 10 Hldgs %
45.13%
Holding
116
New
12
Increased
26
Reduced
50
Closed
24

Top Buys

Rank Stock Value
1
LENZ
LENZ Therapeutics
LENZ
+$20.9M
2
BOLD
Boundless Bio
BOLD
+$12.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$3.72M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.08M
5
PGNY icon
Progyny
PGNY
+$2.87M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.69M
2
EWTX icon
Edgewise Therapeutics
EWTX
+$3.59M
3
ANNX icon
Annexon
ANNX
+$2.96M
4
FDMT icon
4D Molecular Therapeutics
FDMT
+$2.89M
5
VERA icon
Vera Therapeutics
VERA
+$2.82M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
101
Iovance Biotherapeutics
IOVA
$1.95B
– –
-198,800
Closed -$1.62M
PMVP icon
102
PMV Pharmaceuticals
PMVP
$62.4M
– –
-685,985
Closed -$2.13M
PRTA icon
103
Prothena Corp
PRTA
$444M
– –
-46,777
Closed -$1.7M
PRVA icon
104
Privia Health
PRVA
$3B
– –
-90,310
Closed -$2.08M
QURE icon
105
uniQure
QURE
$3.03B
– –
-292,592
Closed -$1.98M
REPL icon
106
Replimune Group
REPL
$1B
– –
-305,412
Closed -$2.57M
SNDX icon
107
Syndax Pharmaceuticals
SNDX
$1.69B
– –
-92,060
Closed -$1.99M
STRO icon
108
Sutro Biopharma
STRO
$425M
– –
-62,368
Closed -$2.68M
TVTX icon
109
Travere Therapeutics
TVTX
$5.21B
– –
-274,623
Closed -$2.47M
XBI icon
110
State Street SPDR S&P Biotech ETF
XBI
$9.92B
– –
-20,439
Closed -$1.82M
ZNTL icon
111
Zentalis Pharmaceuticals
ZNTL
$347M
– –
-7,355
Closed -$111K
AXNX
112
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-32,800
Closed -$2.04M
FUSN
113
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-57,297
Closed -$551K
KRTX
114
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-2,235
Closed -$707K
IMGN
115
DELISTED
Immunogen Inc
IMGN
– –
-17,896
Closed -$531K
MRTX
116
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-6,474
Closed -$380K
1 2 3 4
5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
BIS
BG Investment Services Hagatna, Guam $120M AUM 17.44% 1-Year Est. Return

Sectoral Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sectoral Asset Management held 116 positions worth $254M, up 9.5% from $232M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sectoral Asset Management's Q1 2024 filing shows 12 new, 26 increased, 50 reduced and 24 closed positions. Its largest new stake was Boundless Bio: 855,875 shares worth $12.2M. The largest sale was Amgen, an estimated $3.69M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • Sectoral Asset Management's largest Q1 2024 buy was Boundless Bio: 855,875 shares worth $12.2M.
  • Sectoral Asset Management added most to LENZ Therapeutics in Q1 2024, an estimated $20.9M increase.
  • Sectoral Asset Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $3.69M.
  • Sectoral Asset Management fully exited Edgewise Therapeutics in Q1 2024, selling an estimated $3.59M.
  • Sectoral Asset Management's ten largest holdings make up 45% of its $254M portfolio in Q1 2024.
  • Sectoral Asset Management opened 12 new positions and closed 24 in Q1 2024.
  • Sectoral Asset Management's portfolio value rose 9.5% quarter-over-quarter to $254M.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.